Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BMY
New York
2834
https://www.bms.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bristol-Myers Squibb Co
Data from Phase 2 PILOT Study of Bristol Myers Squibb’s CAR T cell Therapy Breyanzi Show Substantial Durable Responses in Patients with Refractory or Relapsed Large B-cell Lymphoma After First-Line Therapy
- May 26th, 2022 9:00 pm
Top Stock Reports for Tesla, Procter & Gamble & Bristol-Myers Squibb
- May 26th, 2022 3:22 pm
Amgen (AMGN) Ahead of Industry This Year So Far: What's Next?
- May 26th, 2022 11:51 am
Bristol Myers Squibb to Participate in Bernstein’s 38th Annual Strategic Decisions Conference
- May 26th, 2022 10:59 am
Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?
- May 26th, 2022 9:57 am
Investing in Asian American, Native Hawaiian, and Pacific Islander Communities Through Strategic Philanthropic Partnerships
- May 25th, 2022 2:05 pm
10 Recession-Proof Dividend Stocks to Buy
- May 24th, 2022 4:21 pm
Why Roche Needs to Invest in At-Home Diagnostics
- May 24th, 2022 11:44 am
10 Stocks to Buy When Everyone is Selling
- May 23rd, 2022 2:32 pm
Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use
- May 23rd, 2022 2:14 pm
EDP Renewables and Bristol Myers Squibb Execute Power Purchase Agreement for the Cattlemen Solar Park
- May 23rd, 2022 1:33 pm
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
- May 20th, 2022 6:17 pm
The Evolution of Lung Cancer Research
- May 19th, 2022 2:08 pm
Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
- May 19th, 2022 10:59 am
Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates
- May 18th, 2022 3:41 pm
Living Off Dividends in Retirement: 10 Best Stocks To Consider
- May 17th, 2022 6:06 pm
Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
- May 17th, 2022 3:33 pm
Berkshire Hathaway exited Bristol Myers and AbbVie stakes in Q1
- May 16th, 2022 9:53 pm
The Quest To Stop Cancer From Coming Back
- May 16th, 2022 2:16 pm
Bristol Myers' Opdivo+Yervoy Fails To Meet Survival Endpoint In Untreated Urothelial Cancer
- May 16th, 2022 1:56 pm
Scroll